While urolithin A may be able to promote better mitochondrial health by supporting mitophagy,7 there currently isnt any research to suggest that the compound could benefit primary or genetic mitochondrial diseases (e.g., Leigh syndrome, Kearns-Sayre syndrome, Leber hereditary optic neuropathy, etc.).16 Some experts suggest that it could be worth investigating whether mitophagy activation could act as a novel strategy to treat these diseases, but that research hasnt been conducted yet.17 18 19 When that happens, well update this information
Suspected side effects can also be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk
A 2021 randomized controlled trial conducted at Seoul National University enrolled 68 patients with erosive esophagitis (LA Grade B or C)
This process helps with discretion by offering quick, private access to the drugs
Zero Financial Risk : With free evaluations, you will only be charged if prescribed medication
Keeping a food diary can increase awareness of eating patterns and help identify triggers for overeating